Triamcinolone Acetonide 10mg bulk supplier for pharma manufacturers

Triamcinolone Acetonide 10Mg 10 mg/mL, 40 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 10 mg/mL, 40 mg/mL

Reference Brands: Kenalog®(EU & US); Kenalog®, Lederspan®(EU)

Triamcinolone Acetonide is a long-acting corticosteroid used for chronic allergies, arthritis, and inflammatory skin conditions. Available in 10 mg/mL and 40 mg/mL suspensions under brands like Kenalog® and Kenacort® in the EU and US.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Triamcinolone Acetonide 10Mg? List it or send an offer →

Product Description:

Triamcinolone Acetonide Injection is a long-acting corticosteroid used for treating chronic allergic reactions, arthritis, dermatologic conditions, and respiratory inflammation. Available in 10 mg/mL and 40 mg/mL injectable suspensions, it is administered via IM or intra-articular routes. Trusted brands include Kenalog®, Kenacort®, and Lederspan®, widely distributed across the EU and US. Manufactured in GMP-compliant facilities, the product is ideal for B2B supply, hospital tenders, and private labeling. Triamcinolone’s extended-release action makes it a preferred option in long-term care.

Triamcinolone Acetonide 10Mg — third party manufacturing & bulk supply

Triamcinolone Acetonide 10Mg 10 mg/mL, 40 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Triamcinolone Acetonide 10Mg is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Triamcinolone Acetonide 10Mg listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Triamcinolone Acetonide 10Mg →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Triamcinolone acetonide is used to treat various inflammatory and allergic conditions, including skin disorders (such as eczema, dermatitis, and psoriasis), allergic rhinitis, arthritis, and certain mouth ulcers. It is a corticosteroid that works by reducing inflammation, redness, swelling, and itching associated with allergic and immune-mediated reactions.

Triamcinolone acetonide is made from the active ingredient triamcinolone acetonide, a synthetic corticosteroid derived from triamcinolone. Its chemical name is 9-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone. Inactive ingredients vary depending on the dosage form, such as creams, injections, or nasal sprays.

The trade names of triamcinolone acetonide include Kenalog, Nasacort, Aristocort, and Triderm, depending on the formulation and country.

Triamcinolone acetonide (Kenalog) was originally developed by Bristol-Myers Squibb and is now manufactured by several pharmaceutical companies globally, including Teva, Glenmark, and Sun Pharma, under various brand names.

The generic name of the drug is triamcinolone acetonide.

The brand names include Kenalog, Aristocort, Nasacort, and Triderm.

Triamcinolone acetonide is manufactured in multiple countries, including the United States, the United Kingdom, and India, by companies such as Bristol-Myers Squibb, Teva, and Sun Pharma, depending on the formulation and market.